TTUHSC School of Pharmacy
HomeSOPFaculty & Staff Directory

Faculty & Staff Details






Profile for Krystal Edwards, PharmD, FCCP, BCPS

Krystal Edwards

Krystal Edwards, PharmD, FCCP, BCPS

  • Associate Professor of Pharmacy Practice
  • Visiting Clinical Professor, Clinical Pharmacy Division
  • Clinical Pharmacy Specialist, Pharmacotherapy Clinic
Office Phone: 214-372-5300
Email: Krystal.Edwards@ttuhsc.edu
Mail Address: 4500 S Lancaster Rd Bldg 7
Dallas TX 75216-7167

Biography

Dr. Edwards is an Associate Professor in the Ambulatory Care Division on the Dallas/Fort Worth Campus. Dr. Edwards completed her Pharmacy Practice Residency at Baptist Memorial Healthcare in Memphis, Tennessee and a Specialty Residency in Primary Care Pharmacy Practice at the University of Tennessee Medical Center in Knoxville, Tennessee. She became a Board Certified Pharmacotherapy Specialist (BCPS) in December 2003. She was inducted as Fellow of the American College of Clinical Pharmacy in October of 2012. Dr. Edwards started the Dallas/Fort Worth PGY2 Ambulatory Care Specialty Residency and was the residency program director from 2005 to 2012. Dr. Edwards currently practices at the Veterans Affairs North Texas Health Care System in the Ambulatory Care Outpatient Clinic in Fort Worth. There, she actively participates in managing patients in the areas of diabetes, hypertension, heart failure, coronary artery disease, and hyperlipidemia. Dr. Edwards has provided presentations at local, state, and national professional pharmacy meetings. She has been an invited lecturer at several pharmacy schools in Japan and Thailand and was a keynote speaker at the 1st Annual Meeting of the Japan Pharmaceutical and Diabetes Society in Tokyo, Japan last fall. She is currently active and has held several leadership positions in several local, state, and national professional pharmacy organizations along with working with the local American Diabetes Association.

Research Interests

Diabetes, heart failure, and primary and secondary cardiovascular risk factor reductions (e.g. hypertension, hyperlipidemia, heart failure, coronary artery disease, and diabetes)

Selected Publications:

  • Hadley R, Perdomo L, Baby N, Kildow C, Kildow M, Edwards KL. Utilizing clinical pharmacist specialists to address access to care barriers in the type 2 diabetes (T2DM) veteran population. 2014.
  • Edwards KL, Chastain LM. Guidelines and Treatment of Hyperglycemia. Ambulatory Care Self-Assessment Program. Book 1. 2014;(1):3-25.
  • Walker DY, Edwards KL. Statins in the treatment of asthma. Am J Health Syst Pharm. 2013;70:1661-9.
  • Bullock KC, Edwards KL, Greene RS, Shah SR, Blaszczyk AT. Race as a factor for intensification of diabetes medications. Diabetes Educator. 2013;39:335-343.
  • Edwards KL, Kildow M, Weis J, Irons BK. An update in incretin-based therapy: A focus on glucagon-like peptide 1 receptor agonists. Diabetes Technology and Therapeutics. 2012;(14):951-967.
©